EQRx, Inc.
EQRXDelisted Nov 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001843762
EQRx, Inc. was delisted on Nov 9, 2023; its insiders filed their last Form 4 on Nov 14, 2023; 132 institutions reported holding it in 13F filings for Q3 2023, worth $768.6M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in EQRx, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 65
- −9 vs. Q3 2021
- Shares held
- 321.4M
- +282.9M (+734.5%) vs. Q3 2021
- Total value
- $2.18B
- +$1.81B (+481.1%) vs. Q3 2021
- New holders
- 45
- 4 more added
- Sold out
- 54
- 9 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 132 | $768.6M |
| Q2 2023 | 123 | $659.1M |
| Q1 2023 | 116 | $689.7M |
| Q4 2022 | 109 | $877.5M |
| Q3 2022 | 119 | $1.91B |
| Q2 2022 | 109 | $1.70B |
| Q1 2022 | 90 | $1.40B |
| Q4 2021 | 65 | $2.18B |
| Q3 2021 | 75 | $377.9M |
| Q2 2021 | 32 | $185.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding EQRx, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cowen Investment Management LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −123,225−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −107,813−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −105,290−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Antara Capital LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −56,540−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −45,045−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −42,545−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −40,952−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −27,900−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Radcliffe Capital Management, L.P. | 0 | $0 | 0.00% | −20,589−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,715−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −9,800−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −816−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Omni Partners US LLC | – | – | – | – | Not filed |